SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Zonagen (zona) - good buy?

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Dauntless who wrote (3274)4/1/1998 11:02:00 PM
From: Linda Kaplan  Read Replies (1) of 7041
 
Dauntless,

Viagra COULD be recalled, there's just no reason to think that will happen right now.

Vasomax COULD be approved ten months after Zonagen's filing, but there's not enough reason for me to think that will happen right now. If and when Zonagen files there can be requests for more studies or a rejection. There are a lot of clouds over the efficacy of the drug. And before you run around blaming any questioning on the "shorts" I have to say that I haven't seen this kind of questioning on a lot of other drugs, even though there are always shorts.

You're putting the cart before the horse. With few exceptions, as in the case of very high players, most people GO short because they feel the company is going to fail. They don't GO short intending to cause the company to fail. You call names at me, claiming I have to be short and trying to dismiss my thoughts on that basis, but you just have the whole process backwards.

Linda
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext